-- Products: JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets -- Issue: Health products -- Product safety -- What to do: If you are taking the affected products, speak with your pharmacist as ...
Golden State Medical Supply, Inc. has voluntarily recalled 1 lot of Clopidogrel 75mg Tablets and 1 lot of Atenolol 25mg Tablets due to a report stating that a bottle containing Clopidogrel 75mg ...
Plavix Clopidogrel buy plavix 75 mg advisable to prevent blood clots after a recent heart attack or allergy. It is also important by patients with certain disorders of the incidence or blood vessels.
After a suspected transient ischemic attack, an 81-year-old man who takes 81 mg aspirin daily was placed on clopidogrel (Plavix) 75 mg. Shortly thereafter, he developed easy bruising. Should I reduce ...
Clopidogrel (Aplatin 75) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Aplatin 75) is prescribed either ...
Diminished antiplatelet effect in patients with two loss-of-function alleles of the CYP2C19 gene. Increased risk of bleeding. Premature discontinuation increases risk of cardiovascular events; if ...
Golden State Medical Supply, Incorporated (GSMS, Inc.) - Camarillo, CA has initiated a voluntary recall of the products listed in the table below because a report was received that a bottle containing ...
Bottles of medication designed to keep blood pressure down contained medication designed to help prevent strokes and blood clots in people with heart conditions, causing a recall of one lot of each.
Clopidogrel (Deplatt (150 mg)) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Deplatt (150 mg)) is prescribed ...
Bridgewater/Princeton, NJ-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-Aventis/Bristol-Myers Squibb) for use as a loading dose in acute ...
Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events. We randomly assigned 15,603 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results